domingo, 4 de diciembre de 2022

Combining PARP Inhibitor With Immunotherapy-Does the Promise of Preclinical Data Translate to Clinic? Thawani Rajat et al. JAMA oncology 2022 11

Main|Search|PHGKB

No hay comentarios:

Publicar un comentario